Ticker: FPH Our actual "Magnificent" stock. FPH is the only NZX company that truly rivals US tech multiples. They dominate hospital respiratory hardware globally. The valuation is high, but the moat is deep.
Fisher & Paykel Healthcare trades at a P/E that assumes perfection. Mainfreight rarely dips below a 25x multiple. Because there are only 50 stocks on the main board, global fund managers have nowhere else to park large sums of money, so they bid up these seven names. nzx mag
While we don’t have AI chip makers, we do have an oligopoly of essential industries. These seven companies dominate the NZX 50, offering a mix of , commodity pricing power , and defensive earnings . Ticker: FPH Our actual "Magnificent" stock
Ticker: SPK The telco. No growth, but a fortress balance sheet. Retirees love Spark because the dividend yield (usually 6-7%) is better than a term deposit. It’s the utility of the digital age. The valuation is high, but the moat is deep
If you follow global markets, you’ve heard of the Magnificent Seven : Apple, Microsoft, Nvidia, and the rest of the US tech titans pulling the S&P 500 to new highs.
But here in Aotearoa, we have our own power list. I’m calling it the .